HEADER TRANSFERASE 12-MAR-18 6FYL TITLE X-RAY STRUCTURE OF CLK2-KD(136-496)/CX-4945 AT 1.95A COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE CLK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: CDC-LIKE KINASE 2; COMPND 6 EC: 2.7.12.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CLK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS SPLICING, PHOSPHOTRANSFERASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.KALLEN REVDAT 6 17-JAN-24 6FYL 1 REMARK REVDAT 5 06-NOV-19 6FYL 1 REMARK REVDAT 4 03-OCT-18 6FYL 1 REMARK REVDAT 3 26-SEP-18 6FYL 1 JRNL REVDAT 2 12-SEP-18 6FYL 1 JRNL REVDAT 1 18-JUL-18 6FYL 0 JRNL AUTH J.KALLEN,C.BERGSDORF,B.ARNAUD,M.BERNHARD,M.BRICHET, JRNL AUTH 2 A.COBOS-CORREA,A.ELHAJOUJI,F.FREULER,I.GALIMBERTI, JRNL AUTH 3 C.GUIBOURDENCHE,S.HAENNI,S.HOLZINGER,J.HUNZIKER,A.IZAAC, JRNL AUTH 4 M.KAUFMANN,L.LEDER,H.J.MARTUS,P.VON MATT,V.POLYAKOV, JRNL AUTH 5 P.ROETHLISBERGER,G.ROMA,N.STIEFL,M.UTENG,A.LERCHNER JRNL TITL X-RAY STRUCTURES AND FEASIBILITY ASSESSMENT OF CLK2 JRNL TITL 2 INHIBITORS FOR PHELAN-MCDERMID SYNDROME. JRNL REF CHEMMEDCHEM V. 13 1997 2018 JRNL REFN ESSN 1860-7187 JRNL PMID 29985556 JRNL DOI 10.1002/CMDC.201800344 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.57 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 24090 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1268 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2834 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 316 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.11 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.49000 REMARK 3 B22 (A**2) : -1.18000 REMARK 3 B33 (A**2) : -0.31000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.199 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.154 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.093 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.252 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6FYL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-MAR-18. REMARK 100 THE DEPOSITION ID IS D_1200009139. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-APR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99998 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25359 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 19.570 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.30 REMARK 200 R MERGE FOR SHELL (I) : 0.88700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6FYI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% JEFFAMINE ED-2001, 0.1M HEPES, PH REMARK 280 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.81550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.85050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.99850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.85050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.81550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.99850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 134 REMARK 465 PRO A 135 REMARK 465 SER A 136 REMARK 465 SER A 137 REMARK 465 ARG A 138 REMARK 465 ARG A 139 REMARK 465 ALA A 140 REMARK 465 LYS A 141 REMARK 465 SER A 142 REMARK 465 VAL A 143 REMARK 465 ALA A 484 REMARK 465 GLU A 485 REMARK 465 PRO A 486 REMARK 465 PRO A 487 REMARK 465 ASN A 488 REMARK 465 LYS A 489 REMARK 465 LEU A 490 REMARK 465 TRP A 491 REMARK 465 ASP A 492 REMARK 465 SER A 493 REMARK 465 SER A 494 REMARK 465 ARG A 495 REMARK 465 ASP A 496 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 162 -49.24 -150.70 REMARK 500 THR A 289 -13.97 78.44 REMARK 500 ASP A 327 80.92 60.39 REMARK 500 SER A 343 150.35 74.63 REMARK 500 ARG A 345 -60.14 -27.22 REMARK 500 SER A 359 -145.89 -150.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 3NG A 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6FYI RELATED DB: PDB REMARK 900 RELATED ID: 6FYK RELATED DB: PDB DBREF 6FYL A 136 496 UNP P49760 CLK2_HUMAN 135 495 SEQADV 6FYL GLY A 134 UNP P49760 CLONING ARTIFACT SEQADV 6FYL PRO A 135 UNP P49760 CLONING ARTIFACT SEQRES 1 A 363 GLY PRO SER SER ARG ARG ALA LYS SER VAL GLU ASP ASP SEQRES 2 A 363 ALA GLU GLY HIS LEU ILE TYR HIS VAL GLY ASP TRP LEU SEQRES 3 A 363 GLN GLU ARG TYR GLU ILE VAL SER THR LEU GLY GLU GLY SEQRES 4 A 363 THR PHE GLY ARG VAL VAL GLN CYS VAL ASP HIS ARG ARG SEQRES 5 A 363 GLY GLY ALA ARG VAL ALA LEU LYS ILE ILE LYS ASN VAL SEQRES 6 A 363 GLU LYS TYR LYS GLU ALA ALA ARG LEU GLU ILE ASN VAL SEQRES 7 A 363 LEU GLU LYS ILE ASN GLU LYS ASP PRO ASP ASN LYS ASN SEQRES 8 A 363 LEU CYS VAL GLN MET PHE ASP TRP PHE ASP TYR HIS GLY SEQRES 9 A 363 HIS MET CYS ILE SER PHE GLU LEU LEU GLY LEU SER THR SEQRES 10 A 363 PHE ASP PHE LEU LYS ASP ASN ASN TYR LEU PRO TYR PRO SEQRES 11 A 363 ILE HIS GLN VAL ARG HIS MET ALA PHE GLN LEU CYS GLN SEQRES 12 A 363 ALA VAL LYS PHE LEU HIS ASP ASN LYS LEU THR HIS THR SEQRES 13 A 363 ASP LEU LYS PRO GLU ASN ILE LEU PHE VAL ASN SER ASP SEQRES 14 A 363 TYR GLU LEU THR TYR ASN LEU GLU LYS LYS ARG ASP GLU SEQRES 15 A 363 ARG SER VAL LYS SER THR ALA VAL ARG VAL VAL ASP PHE SEQRES 16 A 363 GLY SER ALA THR PHE ASP HIS GLU HIS HIS SER THR ILE SEQRES 17 A 363 VAL SER THR ARG HIS TYR ARG ALA PRO GLU VAL ILE LEU SEQRES 18 A 363 GLU LEU GLY TRP SER GLN PRO CYS ASP VAL TRP SER ILE SEQRES 19 A 363 GLY CYS ILE ILE PHE GLU TYR TYR VAL GLY PHE THR LEU SEQRES 20 A 363 PHE GLN THR HIS ASP ASN ARG GLU HIS LEU ALA MET MET SEQRES 21 A 363 GLU ARG ILE LEU GLY PRO ILE PRO SER ARG MET ILE ARG SEQRES 22 A 363 LYS THR ARG LYS GLN LYS TYR PHE TYR ARG GLY ARG LEU SEQRES 23 A 363 ASP TRP ASP GLU ASN THR SER ALA GLY ARG TYR VAL ARG SEQRES 24 A 363 GLU ASN CYS LYS PRO LEU ARG ARG TYR LEU THR SER GLU SEQRES 25 A 363 ALA GLU GLU HIS HIS GLN LEU PHE ASP LEU ILE GLU SER SEQRES 26 A 363 MET LEU GLU TYR GLU PRO ALA LYS ARG LEU THR LEU GLY SEQRES 27 A 363 GLU ALA LEU GLN HIS PRO PHE PHE ALA ARG LEU ARG ALA SEQRES 28 A 363 GLU PRO PRO ASN LYS LEU TRP ASP SER SER ARG ASP HET 3NG A 501 25 HETNAM 3NG 5-[(3-CHLOROPHENYL)AMINO]BENZO[C][2,6]NAPHTHYRIDINE-8- HETNAM 2 3NG CARBOXYLIC ACID FORMUL 2 3NG C19 H12 CL N3 O2 FORMUL 3 HOH *316(H2 O) HELIX 1 AA1 VAL A 198 ASP A 219 1 22 HELIX 2 AA2 SER A 249 ASN A 257 1 9 HELIX 3 AA3 PRO A 263 ASN A 284 1 22 HELIX 4 AA4 LYS A 292 GLU A 294 5 3 HELIX 5 AA5 THR A 344 ARG A 348 5 5 HELIX 6 AA6 ALA A 349 LEU A 354 1 6 HELIX 7 AA7 GLN A 360 GLY A 377 1 18 HELIX 8 AA8 ASP A 385 GLY A 398 1 14 HELIX 9 AA9 PRO A 401 THR A 408 1 8 HELIX 10 AB1 LYS A 410 LYS A 412 5 3 HELIX 11 AB2 THR A 425 CYS A 435 1 11 HELIX 12 AB3 PRO A 437 LEU A 442 5 6 HELIX 13 AB4 ALA A 446 LEU A 460 1 15 HELIX 14 AB5 THR A 469 LEU A 474 1 6 HELIX 15 AB6 GLN A 475 ALA A 480 5 6 SHEET 1 AA1 6 TRP A 158 LEU A 159 0 SHEET 2 AA1 6 TYR A 163 GLU A 171 -1 O TYR A 163 N LEU A 159 SHEET 3 AA1 6 GLY A 175 ASP A 182 -1 O GLN A 179 N VAL A 166 SHEET 4 AA1 6 ARG A 189 ILE A 195 -1 O ILE A 194 N ARG A 176 SHEET 5 AA1 6 HIS A 238 GLU A 244 -1 O ILE A 241 N LYS A 193 SHEET 6 AA1 6 MET A 229 TYR A 235 -1 N PHE A 230 O SER A 242 SHEET 1 AA2 2 LEU A 286 THR A 287 0 SHEET 2 AA2 2 THR A 332 PHE A 333 -1 O THR A 332 N THR A 287 SHEET 1 AA3 2 ILE A 296 PHE A 298 0 SHEET 2 AA3 2 VAL A 323 VAL A 325 -1 O ARG A 324 N LEU A 297 SHEET 1 AA4 2 TYR A 303 ASN A 308 0 SHEET 2 AA4 2 ARG A 313 VAL A 318 -1 O GLU A 315 N THR A 306 SHEET 1 AA5 2 PHE A 414 TYR A 415 0 SHEET 2 AA5 2 ARG A 418 LEU A 419 -1 O ARG A 418 N TYR A 415 SITE 1 AC1 15 LEU A 169 GLY A 170 GLU A 171 PHE A 174 SITE 2 AC1 15 ALA A 191 LYS A 193 PHE A 243 GLU A 244 SITE 3 AC1 15 LEU A 246 LEU A 297 VAL A 326 ASP A 327 SITE 4 AC1 15 HOH A 611 HOH A 634 HOH A 788 CRYST1 39.631 75.997 111.701 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025233 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013158 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008952 0.00000